Glaucot Teknoloji Anonim Sirketi's GlaucoT glasses represent an innovative approach to treating POAG by utilizing flicker light therapy, which has shown promise in neuroprotection. Given the increasing prevalence of glaucoma, projected to affect over 60 million individuals globally, this device could address a significant unmet need in the market. The competitive landscape includes traditional IOP-lowering medications and surgical interventions, but GlaucoT's non-invasive, cost-effective solution may appeal to patients seeking alternatives. Successful outcomes could position Glaucot as a leader in glaucoma management, potentially leading to partnerships or licensing opportunities within the ophthalmic device sector.